Echo IQ is trading 6.72% down at A$0.62, with no clear company-specific catalyst identified for September 25.
- Shares closed at A$0.67 on September 24, 2026.
- ASX listings show the latest material disclosure remained the September 17 EchoSolv HF FDA update. It described potential regulatory pathways but does not directly explain todayβs decline.
- Broader market indices were flat, leaving macro sentiment inconclusive.